Acomo (ACOMO) CMD 2025 summary
Event summary combining transcript, slides, and related documents.
CMD 2025 summary
29 Nov, 2025Strategic objectives and growth plans
Aiming to grow sales to €2 billion in the midterm, with a targeted EBITDA margin of 9% and leverage ratio below 2.5x, combining organic growth and acquisitions.
Focused on expanding in spices and nuts, edible seeds, organic ingredients, tea, and food solutions, with both autonomous growth and M&A, especially in Europe and North America.
Plans to introduce a customer-centric model in tea and invest in food solutions, including new processing capabilities and bolt-on acquisitions.
Maintains a strong balance sheet, attractive dividend policy with payout above 70%, and prudent capital allocation to support growth and shareholder value.
Growth strategy combines 5% annual organic growth with selective transformational M&A, supported by robust solvency and financial headroom.
Business model and market positioning
Operates in specialty, non-listed plant-based ingredients, focusing on sourcing, trading, processing, and distribution, with a diversified product and customer base of over 600 products.
Leverages deep market knowledge, long-term supplier relationships, and local presence to ensure supply security and quality.
Vertical integration and innovation in segments like sunflower seeds and organic ingredients drive higher margins and customer loyalty.
Sustainability, traceability, and responsible sourcing are integral, with investments in digital tools, regenerative agriculture, and ESG.
Each operating entity retains entrepreneurial freedom, fostering agility and reliability across the group.
Financial performance and guidance
Sales and EBITDA have doubled over the past five years, with organic growth averaging 5% and EBITDA growth at 13% annually.
Financial targets include maintaining a 9% EBITDA margin, strong solvency, and a dividend payout ratio above 70%.
Acquisition strategy prioritizes non-listed specialty commodities with margin profiles aligned to the group, focusing on strategic, financial, and cultural fit.
Capital intensity will remain relatively asset-light, but value-adding assets are considered if aligned with the business model.
Proven track record: 8% annual sales growth (4% organic), steady EBITDA, and consistent dividend payout over the past decade.
Latest events from Acomo
- Record results driven by strong segment growth, with sustainability and normalization ahead.ACOMO
H2 20256 Mar 2026 - EBITDA fell 9% as cocoa volatility offset record Spices & Nuts growth; dividend held at €0.40.ACOMO
H1 20243 Feb 2026 - Record sales and EBITDA growth in 2024, driven by strong H2 and segment outperformance.ACOMO
H2 202423 Dec 2025 - Record H1 2025 sales and profit growth, driven by Spices & Nuts and Organic Ingredients.ACOMO
H1 202516 Nov 2025 - Q3 sales up 6% to €357.3M, led by Spices, Nuts, and Organic Ingredients; US remains challenging.ACOMO
Q3 2025 TU23 Oct 2025 - Q3 revenue up 14% year-over-year, led by Spices and Nuts and Organic Ingredients growth.ACOMO
Q3 2024 TU13 Jun 2025